Milestone Scientific (AMEX:MLSS) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 50 percent increase over losses of $(0.02) per share from the same period last year. The company reported quarterly sales of $2.841 million which beat the analyst consensus estimate of $2.700 million by 5.22 percent. This is a 22.30 percent increase over sales of $2.323 million the same period last year.